Urgent need for more research into environmental effects of microplastics Additional solutions are urgently needed to limit emissions of microplastics into the environment. Growing quantities of microplastics (particles of 5 mm or less) are entering our living environment every day.
Proposed European PFAS ban officially submitted The Netherlands, Germany, Denmark, Sweden and Norway today took the first formal step towards a European ban on per- and polyfluoroalkyl substances (PFAS) by jointly submitting a restriction proposal to the European Chemicals Agency (ECHA).
More than two million invitations to get vaccinated against HPV in 2023 In early 2023, 1.3 million young adults will receive an invitation to get vaccinated against the human papillomavirus (HPV). This group comprises around 900,000 men and 400,000 women between the ages of 19 and 27.
Minor decrease in percentage of people who tested positive, slower increase in hospital and ICU admissions In the past week, from 23 to 29 December, the reported number of people who tested positive for COVID-19 was 67,388. This is a slight decrease of 11.7% compared to the week of 16 to 22 December.
The spread of the UK coronavirus variant in the Netherlands The UK variant of the coronavirus (SARS-CoV-2) has been found in 11 people in the Netherlands so far: 5 people in the Amsterdam region, 5 people in the Rotterdam region and 1 person in the Nijmegen
All signals still on red The advance of the coronavirus (SARS-COV-2) in the Netherlands continues unabated. It is still too early to see the effects of the lockdown that was announced on 15 December.
Improvement of air quality continues In 2019, the calculated concentrations of nitrogen dioxide (NO2) and particulate matter (PM10) were below the European limit values in almost the whole of the Netherlands. Locally, the limit value for nitrogen dioxide is still being exceeded.
RIVM international circular economy knowledge partner As of 7 December 2020, RIVM has become a knowledge partner of the international Platform for Accelerating the Circular Economy (PACE).
First COVID-19 vaccination in the Netherlands on 8 January 2021 If the European Medicines Agency (EMA) approves BioNTech/Pfizer’s COVID-19 vaccine next week, the first people in the Netherlands will receive the COVID-19 vaccine on Friday 8 January 2021.
First wave of COVID-19 had major impact on regular healthcare and health During the first wave, the novel coronavirus (SARS-CoV-2) had a major impact on healthcare in the Netherlands. Many patients faced delays in appointments and treatments.